GKT-04 program (GenKyoTex)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGKT-04 program (GenKyoTex)
Drug Alias NameNADPH oxidase 2 inhibitor (GenKyoTex)GKT-04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH Oxidase 2 inhibitors
TargetsNADPH Oxidase 2
Therapy Area/IndicationsAngiogenesis disorderHyperoxiaHeart Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalliditas Therapeutics Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalliditas Therapeutics Ab
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderHyperoxiaHeart Diseases

Other Information

ATC CodeN/A
Related LinksN/A